Immunopotentiators in modern vaccines /
Saved in:
Edition: | Second edition. |
---|---|
Imprint: | Amsterdam : Academic Press, [2017] ©2017 |
Description: | 1 online resource (xvii, 490 pages) : illustrations |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11268948 |
Table of Contents:
- Vaccine adjuvants' mode of action: unraveling "the Immunologist's Dirty Little Secret" / V.E.J.C. Schijns
- The role of inflammasomes in adjuvant-driven humoral and cellular immune responses / N. Muñoz-Wolf, S. McCluskey, E.C. Lavelle
- Dendritic cells as targets of vaccines and adjuvants / M.M. Strioga, N.T. Dobrovolskiene
- Host-derived cytokines and chemokines as vaccine adjuvants / W.G.J. Degen, V.E.J.C. Schijns
- Discovery of immune potentiators as vaccine adjuvants / C. Buonsanti, U. D'oro
- Current status of toll-like receptor 4 ligant vaccine adjuvants / C.B. Fox, D. Carter, R.M. Kramer, A.M. Beckmann, S.G. Reed
- Flagellins as adjuvants of vaccines / M. Rumbo, C. Carnoy, J.C. Sirard
- Toll-like receptor 7 and 8 agonists for vaccine adjuvant use / M.A. Tomai, J.P. Vasilakos
- CpG Oligodeoxynucleotides as adjuvants for clinical use / H. Shirota, D.M. Klinman
- Advax adjuvant: a potent and safe immunopotentiator composed of delta inulin / N. Petroski
- Natural vaccine adjuvants and immunopotentiators derived from plants, fungi, marine organisms, and insects / N. Woods, K. Niwasbutra, R. Acevedo, J. Igoli, N.A. Altwaijry, J. Tusiimire, A.I. Gray, D.G. Watson, V.A. Ferro
- Polymeric particles as vaccine delivery systems / P. Malyala, D.T. O'Hagen
- MF59: a safe and potent adjuvant for human use / S. Kommareddy, M. Singh, D.T. O'Hagan
- The development of the adjuvant system AS01: a combination of two immunostimulants MPL and QS-21 in liposomes / A.M. Didierlaurent, A. Berger, T.C. Heineman, V. Henderickx, F. Tavares Da Silva, J. Vekemans, G. Voss, N. Garçon
- Development and evaluation of AS04, a novel and improved adjuvant system containing 3-0-Desacyl-4'- monophosphoryl lipid A and aluminum salt / N. Garçon, F. Tavares Da Silva
- ISCOMATRIX adjuvant in the development of prophylactic and therapeutic vaccines / A.B. Morelli, E. Maraskovsky
- Development and evaluation of CAF01 / D. Christensen
- Mineral adjuvants / E.B. Lindblad, L. Duroux
- Toxin-based mucosal adjuvants / A.M. Harandi, N. Lycke
- Adjuvants for skin vaccination / I. Skountzou, N. Brock, N. Lelutiu, R.W. Compans
- Vaccination to treat noninfectious diseases: surveying the opportunities / M.F. Bachmann, M. Vogel
- A framework for evaluating nonclinical safety of novel adjuvants and adjuvanted preventive vaccines / P.E. Boucher.